UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Anesthesia Clinical Trials Unit (ACTU), an...

MaRS Innovation Launches New Drug Discovery Program Targeting Rare and Disabling Developmental Disorder Toronto, ON, July 15, 2019 (GLOBE NEWSWIRE) -- MaRS Innovation announced today that it is partnering with Dr. James Eubanks at the University Health Network (UHN) to develop a new treatment for Rett...

Enwave and University Health Network team up to control energy costs, improve reliability and support patient care TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Enwave Energy Corporation (Enwave) is working with the University Health Network (UHN) to connect the Princess Margaret Cancer Centre to Enwave’s Deep...

LAB150 awards its second drug discovery project from Canada’s largest research based Hospital, The University Health Network (UHN) Toronto, ON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- MaRS Innovation announced today the second project to be developed under their LAB150 partnership with Evotec.   The project aims to develop a...